Main Article Content
ST-elevation myocardial infarction (STEMI), Admission Glucose Level, In-Hospital Outcomes, Hyperglycemia, Euglycemia
Objective: To determine the in-hospital outcomes of patients with STEMI and its correlation with admission glucose level.
Methodology: The study comprised of 280 patients diagnosed with ST-elevation myocardial infarction (STEMI) enrolled during the period March 2023 till September 2023. Admission glucose levels and clinical and biochemical parameters were noted. Hyperglycemia was defined as blood glucose levels more than 140 mg/dl in our study. Hypertension was defined as systolic blood pressure more than 140 mmHg or diastolic blood pressure greater than 90 mmHg. Outcomes were noted in terms of mortality and compared with admission glycemia.
Results: 192 (68.57%) were male and 88 (31.43%) were female, with a mean age of 59.8 ±12 years. The hyperglycemic group included 106 patients (78 males, 73.58%; 28 female, 26.42%) and the euglycemic group 174 (114 male, 65.52%; 60 female, 34.48%; p = 0.03). 110 (39.28%) had hypertension. Of 98 (35.9%) diabetic patients hospitalized, 82 (77.36%) had hyperglycemia and 16 (22.64%) had euglycemia. Overall mortality was 7.71 (n = 16), 14 patients (17.07) among hyperglycemics and 02 (8.0%) among euglycemics.
Conclusion: In patients with STEMI, hyperglycemia significantly worsens in-hospital outcomes for patients. Higher death rates are seen in STEMI patients who had hyperglycemia at hospital admission.
2. Babes EE, Bustea C, Behl T, Abdel-Daim MM, Nechifor AC, Stoicescu M, et al. Acute coronary syndromes in diabetic patients, outcome, revascularization, and antithrombotic therapy. Biomed Pharmacother. 2022; 148:112772.
3. Muacevic A, Adler JR, Shahid M, Zarif HMA, Farid MS, Muhammad Shoaib Abid MS, et al. Prognostic Value of Hyperglycemia on Admission on In-hospital Outcomes in Patients Presenting with ST-elevation Myocardial Infarction. Cureus. 2020; 12(2): e7024.
4. Ali J, Haider SMS, Ali MS, Haider T, Anwar A, and Hashmi AA, Overall Clinical Features of Type 2 Diabetes Mellitus With Respect to Gender. Cureus. 2023; 15(3): e35771.
5. Zhou M, Liu J, Hao Y, Liu J, Huo Y, Smith SC, et al. Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project. Cardiovasc Diabetol 2018; 17: 147.
6. Takada JY, Ramos RB, Roza LC, Avakian SD, Ramires JA, Mansur Ade P. In-hospital death in acute coronary syndrome was related to admission glucose in men but not in women. Cardiovasc Diabetol. 2018; 11:47.
7. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119-177.
8. Khalfallah M, Abdelmageed R, Elgendy E, Hafez YM. Incidence, predictors and outcomes of stress hyperglycemia in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention. Diab Vasc Dis Res. 2020;17(1):1479164119883983.
9. Grodzinsky A, Arnold SV, Jacob D, Draznin B, Kosiborod M. The impact of cardiovascular drugs on glycemic control: a review. Endocr pract. 2017;23(3):363-371.
10. Triggle CR, Ding H. Cardiovascular impact of drugs used in the treatment of diabetes. Ther Adv Chronic Dis. 2018;5(6):245-68.
11. Kewcharoen J, Ali M, Trongtorsak A, Mekraksakit P, Vutthikraivit W, Kanjanauthai S. Admission hyperglycemia is associated with reperfusion failure in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis. Am J Cardiovasc Dis. 2021;11(3):348-359.
12. Nishihira K, Kojima S, Takegami M, Honda S, Nakao YM, Takahashi J, et al. Clinical Characteristics and In-Hospital Mortality According to Left Main and Non-Left Main Culprit Lesions - Report From the Japan Acute Myocardial Infarction Registry (JAMIR). Circ Rep. 2019;1(12):601-609.
13. Sasso FC, Rinaldi L, Lascar N, Marrone A, Pafundi PC, Adinolfi LE, et al. Role of Tight Glycemic Control during Acute Coronary Syndrome on CV Outcome in Type 2 Diabetes. J Diabetes Res. 2018; 2018:3106056.
14. Savonitto S, Morici N, De Servi S. Update: acute coronary syndromes (VI): treatment of acute coronary syndromes in the elderly and in patients with comorbidities. Rev Esp Cardiol (Engl Ed). 2019;67(7):564-73.